PMID: 15243216Jul 10, 2004Paper

Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm

Current Opinion in Lipidology
Allan D Sniderman

Abstract

The first objective is to present the most recent evidence relating to the efficacy of apolipoprotein B as a diagnostic index of the risk of vascular disease and a therapeutic target for statin therapy. The second is to present a diagnostic algorithm for the apolipoprotein B100 dyslipidemias based on triglyceride and apoB. The results from several recent prospective epidemiological studies demonstrate apoB to be superior to any of the cholesterol indices to estimate the risk of vascular disease. Similarly, the results of several of the major statin clinical trials demonstrate that apoB is a more adequate index of the adequacy of statin therapy than any of the cholesterol indices. Recent studies of lipoprotein subclass distribution in subjects with familial combined hyperlipidemia are reviewed. They demonstrate the limitations of the original lipid-based criteria and point to the necessity of using apoB as a fundamental diagnostic criterion for the disorder. A diagnostic algorithm for an apoB100 atherogenic dyslipoproteinemias is presented and the limitations of the lipid-based system described. The evidence supporting the clinical use of apoB is solid, its measurement is standardized, and automated, inexpensive laboratory testi...Continue Reading

References

Jan 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·C J Packard, J Shepherd
Jul 27, 2001·The American Journal of Cardiology·C M BallantyneUNKNOWN ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study
Feb 9, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Mario J VeerkampAnton F H Stalenhoef
Sep 18, 2002·Journal of Lipid Research·Kaspar K Berneis, Ronald M Krauss
Nov 7, 2002·The American Journal of Cardiology·James D OtvosWilliam C Cromwell
Nov 12, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Philippa J TalmudSteve E Humphries
May 15, 2003·The American Journal of Cardiology·Allan D SnidermanBenoît Lamarche
Jul 18, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Valentine C MenysPaul N Durrington
Aug 5, 2003·Journal of Lipid Research·Tsutomu HiranoGen Yoshino

❮ Previous
Next ❯

Citations

Jul 20, 2010·Journal of Thrombosis and Thrombolysis·David KarasekDalibor Novotny
Aug 11, 2006·Current Diabetes Reports·Warren H Capell, Robert H Eckel
Mar 25, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·A H WuT G Cole
Jan 14, 2009·Nature Reviews. Genetics·Robert A Hegele
Apr 9, 2011·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·David KarasekDalibor Novotny
Oct 18, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·David KarasekDalibor Novotny
May 24, 2007·Current Medical Research and Opinion·B IlerigelenUNKNOWN TULIPS Investigators
Nov 22, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Benoît Lamarche, Annie C St-Pierre
Nov 23, 2006·Contemporary Clinical Trials·Lewis H KullerMolly B Conroy
Aug 13, 2010·European Journal of Clinical Investigation·Benoit J ArsenaultS Matthijs Boekholdt
Sep 29, 2015·Health Policy and Planning·Manuela ColombiniUNKNOWN ADVANCE Study Team
Oct 22, 2003·Archives of Medical Research·Segundo MoránMisael Uribe
May 6, 2017·Journal of Lipids·Wenyu WangElisa Lee
Sep 21, 2018·Lipids in Health and Disease·Liangcai GaoXinnan Liu
Jun 6, 2015·Critical Reviews in Food Science and Nutrition·Neetu Miglani, Kiran Bains
Aug 24, 2011·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Maurizio AvernaPhilippe Brudi
Nov 9, 2004·European Journal of Clinical Investigation·D C Chan, G F Watts

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.